Complete Classic Medium Kit With Serum and CultureBoost

Certificate #: 4Z0-500

Introduction

Medium is formulated with 10% serum. Kit consists of 500mL CSC Medium, 10mL CultureBoost (containing animal derived growth factors) and 10mL Attachment Factor™. This becomes a complete medium once activated with the included CultureBoost supplement. 4Z0-500 is Certified and intended for experimental application. CSC media and reagents are Sterile, made with WFI and all components are cGMP and ISO Compliant.

Available Formats

Available in one 500 mL container or a 10 pack of 500 mL containers.

Appropriate Use

Certified for use with more than 100 human and animal cell cultures and cell lines including these ACBRI Certified cells:

Human:
Bone Marrow Cells (CFU-F and Erythroid Burst Cultures)
Connective Tissue Cells
Dermal Fibroblast Cells
Endothelial Cells (Aortic, Arterial, Coronary Artery, Vascular and Venous)
Fetal Lung Cells
Embryonic and Adult Stem Cells
Fibroblast Cells
Glomerular Mesangial Cells
Immortalized / Tumor-derived Mesenchymal Cells
Microvascular Cells (Cerebral, Coronary, Dermal, Glomerular, Liver, Lung and Retinal)
Smooth Muscle Cells
Tumor Neovascular Cells
Animal:
Bovine and Porcine large vessel and microvessel Endothelial Cells

Characteristics of CSC Serum-Containing Medium

CSC Medium contains no added hormones.

CSC Medium contains no antibiotics; however, Bac-Off®, Catalog 4Z0-643, is the recommended antibiotic for all CSC medium. Bac-Off® is at or above the [2ng/mL] MIC of aerobic gram-positive and gram-negative microorganisms. (See Bac-Off® certificate.)

CSC Medium contains no phenol red. Phenol red in cell culture medium binds to receptors on cell surfaces and causes the cell to respond as though pharmacologic levels of estrogen and/or inflammatory mediators (such as prostaglandin or thromboxane A2) are present in the medium. It is difficult to understand how a realistic baseline can be ascertained under these conditions. The side-effects of phenol red can be avoided very simply: leave it out. The presence of phenol red is unnecessary and potentially catastrophic to experimentation.

Recommended Companion Products for CSC Medium and CSC / ACBRI Cells: 

Use of Attachment Factor is strongly recommended. Phenotypic and physiologic response motifs are mediated in vivo by cells from information transduced from the extracellular compartment. Culture of differentiated, polar, anchorage dependent cells in any medium requires attention to information processed by the cell from the extracellular matrix (ECM). Attachment Factor™ is an analog for the Natural ECM, provides information to the cell, and helps mediate these processes. Phenol red is NOT included in the formulation. (Refer to the CSC Certificate for Attachment Factor™.)

Use of the Passage Reagent Group (PRG) is strongly recommended. Culture of fastidious cells in any medium requires careful formulation and calibration of reagents in order to detach cells for passage without excessive cytoskeletal and membrane damage. Trypsin is not “inactivated” by serum: the reduction of enzymatic activity on cell membranes is (at best) competitive and may be ineffective. Other enzymes (chymotrypsin, cathepsins, neutral proteases, etc.) not inactivated by serum in commercial (1:250) trypsin preparations make “inactivation” with serum during passage illogical. The PRG was engineered to meet the special challenges of modern cell culture, where thoughtful management of phenotype is important. Refer to the CSC Certificate for PRG.

Use of CSC Cell Freezing Medium is strongly recommended:  Cell Freezing Medium is formulated using conditioned CSC Medium with DMSO as the principal cryoprotective agent. CSC Cell Freezing Medium is qualified by CSC and ACBRI for freezing cells whether cultured in serum-free or serum containing medium. Refer to the CSC Certificate for Cell Freezing Medium. 

Handling

Cell Storage
Remove the vial(s) from the dry ice shipping container and immediately transfer to liquid nitrogen. ALWAYS store cells under liquid nitrogen. Inapparent yet severe damage to membrane and cytoskeletal components results from chronic temperature fluctuations.

Medium Storage
CSC Serum containing Medium is shipped at ambient temperature. If the entire unit will not be used within 30 days, activate the medium with the enclosed supplement then aliquot and freeze in smaller units which will be used within 30 days.

If the full 500mL medium unit will be used within 30 days, immediately refrigerate the medium and supplements.  Once the unit is activated, or any component of the media kit is opened, the shelf life is 30 days at refrigerated (4 - 8°C) temperatures.

 Additional Information

Thawing and Feeding Cells 

  1. Thaw CSC medium. Store refrigerated at 4-8°C.
  2. Warm sufficient activated CSC Medium to 37°C in a water bath.
  3. Thaw the vial(s) of cells by immersing in a 37°C water bath. Observe carefully with gentle agitation and remove from the water bath just before the last of the ice disappears. This ensures that the cells are always kept close to the triple-point of water.
  4. Cleanse the vial(s) with 90% ethanol using a sterile 2X2. 
  5. Immediately transfer the contents of the vial to at least 10 volumes of ice-cold Medium in a sterile centrifuge tube. Keep in an ice/water bath throughout to maintain triple-point temperature: cell viability is negatively affected by temperature excursions.
  6. Centrifuge 100-200 X g, 5-7 minutes refrigerated.
  7. Aspirate and discard supernatant. Leave 100-150 µl fluid to cover the pellet.
  8. Loosen the cell pellet by flicking with fingers.
  9. Count and adjust cell concentration at this time per your usual protocol.
  10. Prepare the new culture surface using Attachment Factor™.
       (a) Warm Attachment Factor™ to 37°C in the water bath.
       (b) Wet the culture surface to be inoculated with Attachment Factor™.
       (c) Aspirate and discard excess. Rinsing and/or drying are NOT necessary.
    The culture may be inoculated at once.
  11. Re-suspend cells in CSC Complete Medium warmed to 37
  12. Seed on a tissue culture surface freshly coated with Attachment Factor.
  13. Incubate @ 37°C, 5% CO2, 100% humidity.
  14. The vial of cells seeds a 75cm sq culture.

For Cell Passage

Refer to Passage Reagent Group™ instructions for more details.

  • To feed, aspirate (and discard) spent medium. Add fresh CSC Medium.
  • Feed at 12-24 hours and at least every 48 hours thereafter.
  • As cultures approach confluence, daily feeding should be considered.

 PMID  Title  Author  Year
21372496 Protective effect of photodegradation product of nifedipine against tumor necrosis factor alpha-induced oxidative stress in human glomerular endothelial cells Yayoi Fukhara 2011
21253500 The Traditional Japanese Formula Keishibukuryogan Inhibits the Production of Inflammatory Cytokines by Dermal Endothelial Cells Yoko Yoshihisa 2010
21151895 Phosphodiesterase-III Inhibitor Prevents Hemorrhagic Transformation Induced by Focal Cerebral Ischemia in Mice Treated with tPA Mitsunori Ishiguro 2010
21109446 Enzymatic synthesis of 125/131I,labeled 8-hydroxyquinoline glucuronide and in vitro/in vivo evaluation of biological influence Reyhan Yesilagac 2011
  20952385 Brain Endothelial Cells Produce Amyloid beta From Amyloid Precursor Protein 770 and Preferentially Secrete The O-Glycosylated Form Shinobu Kitazume  2010
20685820 Nicotine worsens the severity of nephropathy in diabetic mice: implications for the progression of kidney disease in smokers Edgar A. Jaimes 2010
 20578839 Enzymatic Synthesis of Uracil Glucuronide, Labeling with 125/131I, and In Vitro Evaluation on Adenocarcinoma Cells Ilker Emin Medine 2010
20110406 Inhibition of Protein Kinase C o Attenuates Blood-Retinal Barrier Breakdown in Diabetic Retinopathy Jeong-Hun Kim 2010
20011631 BOL-303242-X, a novel selective glucocorticoid receptor agonist, with full anti-inflammatory properties in human ocular cells Jin-Zhong Zhang  2009
 20011081 Extracellular SOD and VEGF are increased in Vitreous bodies from proliferative diabetic retinophathy patients Hideaki Hara  2009
19948061 Characteriztion of TEM1/endosialin in human murine brain tumor Eleanor Carson-Walter  2009
 19875648 Protective Effect of Clusterin on Blood-Retinal Barrier Breakdown in Diabetic Retinopathy Jeong-Hun Kim 2010
 19864304 Human glomerular endothelium: interplay among glucose, free fatty acids, angiotensin II and oxidative stress Edgar A. Jaimes 2009
 19756180 Decursin inhibits retinal neovascularization via suppression of VEGFR-2 activation Jeong Hun Kim  2009
 19397812 Soluble aggregates of the amyloid-beta peptide are trapped by serum albumin to enhance amyloid-beta activation of endothelial cells Melissa A. Moss    2009
19174516 VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown  Gareth R. John    2009
18941231 Cannabinoids Inhibit HIV-1 Gp120-Mediated Insults in Brain Microvascular Endothelial Cells Tzong-Shi Lu   2008
18726995 Thrombospondin-1-induced apoptosis of brain microvascular endothelial cells can be mediated by TNF-R1 Candece L. Gladson  2009
 18702666 Slouble aggregates of the amyloid-beta protein selectively stimulate permeability in human brain microvascular endothelial monolayers Melissa A. Moss  2008
 18599607 Hypoxia- and Vascular Endothelial Growth Factor-Induced Stromal Cell-Derived Factor-1alpha/CXCR4 Expression in Glioblastomas David Zagzag  2008
 18535159 MRP (ABCC) Transporters-Mediated Efflux of Anti-HIV Drugs, Saquinavir and Zidovudine, from Human Endothelial Cells Debasis Mondal   2008
 18354059 Mitochondrial Effects of Estrogen Are Mediated by Estrogen Receptor alpha in Brain Endothelial Cells Ali Razmara  2008
17442832 AKAP 12 Regulates Human Blood-Retinal Barrier Formation by Dounregulation of Hypoxia-Inducible Factor 1 alpha Yoon Kyung Choi  2007 
 17953673 Soluble aggregates of amyloid-beta protein activate endothelial monolayers for adhesion and subsequent transmigration of monocyte cells Melissa A. Moss  2007
17327359 Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury Sandor Batkai   2007
 17399760 Polyomavirus JC Infects Human Brain Microvascular Endothelial Cells Independent of Serotonin Receptor 2A Moti L. Chapagain   2007
17953673 Soluble aggregates of the amyloid-beta protein activate endothelial monolayers for adhesion and subsequent transmigration of monocyte cells Francisco J. Gonzalez-Valasquez  2007
 17384142 Peroxynitrite mediates VEGF's angiogenic signal and function via a nitration-independent  mechanism in endothelial cells Azza B. El-Remessy  2007
17012319 Electron Paramagnetic Resonance Oximetry as a Quantitative Method to Measure Cellular Respiration: A Consideration of Oxygen Diffusion Interference  Tennille Presley  2006
16920799 Nicotine: the link between cigarette smoking and the progression of renal injury. Edgar A. Jaimes   2006
 17075581 Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblasoma: implications for angiogenesis and glioma cell invasions  David Zagzag   2006
 17015745 IL-1beta Regulates Blood-Brain Barrier Permeability via Reactivation of the Hypoxia  Angiogenesis Program Gareth R. John   2006
 16825603 Troglitazone acutely inhibits protein synthesis in endothelial cells via a novel mechanism involving protein phosphatase 2A-dependent p70 S6 kinase inhibition  Du-Hyong Cho   2006 
 15923192 Peptides Derived from Human Decorin Leucine-rich Repeat 5 Inhibit Angiogenesis  K N Sulochana   2005
 15705727 Vascular endothelial wound closure under shear stress: role of membrane fluidity and flow-sensitive ion channels  Abdul I. Barakat   2005
16352855 Role of fibroblast growth factor-binding protein in the pathogenesis of HIV-associated helolytic uremic syndrome  Patricio E. Ray   2005
16131569 Hemolytic uremic syndrome-associated Siga toxins promote endothelial cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers  Leticia H. Nolasco   2005
 14761889 Differential membrane potential and ion current responses to different types of shear stress in vascular endothelial cells.  Abdul I. Barakat   2004
 15615788 Oxidative stress inactivates VEGF survival signaling in retinal endothelial cells via PI 3-kinase tyrosine nitration  Azza B. El-Remessey   2004
 15161644 Endometrial Angiopoietin Expression and Modulation by Thrombin and Steroid Hormones  Graciela Krikun   2004 
 15332016 Delivery of antianglogenic and antioxidant drugs of opthalmic interest through a nanoporous inorganic filter  Kathleen E. Orosz   2004
 15163749 Contribution of Proteoglycans to Human Immunodeficiency Virus Type 1 Brain Invasion  Michael D Bobardt   2004
14610228 Dexamethasone-Mediated Up-Regulation of  the Mannose Receptor Improves the Delivery of Recombinant Glucocerebrosidase to Gaucher Macrophages  Yunsiang Zhu   2003
 12757411 Hepatocyte growth factor activates endothelial nitric oxide synthase by Ca2+  and phosphoinositide 3-kinase/Akt-dependent phosphoryiation in aortic endothelial cells  Kennedy Makondo   2003
12746324  Mouse Endocrine Gland-Derived Vascular Endothelial Growth Factor: A Distinct Expression Pattern from Its Human Ortholog Suggests Different Roles as a Regulator of Organ-Specific Angiogenesis  Napoleone Ferrara  2003
 12704106 Invasion and Killing of Human Endothelial Cells by Viridans Group Streptococci  Murray W. Stinson   2003
 12682234 Expression of the NF-kB Target Gene X-Ray-Inducible Immediate Early Response Factor-1 Shor Enhances TNF alpha-Induced Hepatocyte Apoptosis by Inhibiting Akt Activation  Yosuke Osawa   2003
 14551401 Interactions Between p38 Mitogen-Activated Protein Kinase and Capase-3 in Cerebral Endothelial Cell Death After Hypoxia-Reoxygenation  Sun-Ryung Lee   2003
 12844492 Vascular Endothelial Growth Factor Regulates Focal Adhesion Assembly in Human Brain Microvascular Endtohelial Cells through Activation of the Focal Adhesion Dinase and Related Adhesion Focal Tyrosine Kinase  Shalom Avraham   2003
 12594291 HIV-1 Tat-Mediated Apoptosis in Human Brain Microvascular Endothelial Cells  Shalom Avraham   2003
 12533667 Potential Involvement of the Cycloxygenase-2 Pathway in the Regulation of Tumor-associated Angiogenesis and Growth in Pancreatic Cancer  Maria Teressa Rizzo   2003
 14679308 Integrin-linked kinase regulates vascular morphogenesis induced by vascular endothelial growth factor  Yayoi Kaneko   2003
 12757771 Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis  Joaquin J. Jimenez   2003
 12824281 VEGF differentially activates STAT3 in microvascular endothelial cells  Manuela Bartoli   2003
12824263 High Glucose-Induced Tyrosine Nitration in Endothelial Cells: Tole of eNOS Uncoupling and Aldose Reductase Activation Azza B. El-Remessy   2003
 12736139 Hyperoxia induces retinal vascular endothelial cell apoptosis through formation of peroxynitrite  Azza B. El-Remessy   2003
12213726 Abnormal Uterine Bleeding during Progestin-Only Contraception May Result from Free Radical-Induced Alterations in Angiopoletin Expression  Graciela Krikun   2002
12379708 Tumor Necrosis Factor Alpha-Induced Intereukin-8 Production via NF-kB and Phosphatidylinositol 3-Kinase/Akt Pathways Inhibits Cell Apoptosis in Human Hepatocytes  Yosuke Osawa   2002
 12446667 Vascular Endothelial Growth Factor Modulates the Transendothelial Migration of MDA-231 Breast Cancer Cells through Regulation of Brain Microvascular Endothelial Cell Permeability Shalom Avraham   2002
 11784713 Vascualr Endothelial Growth Factor Modulates Neutrophil Transendothelial Migration via Up-Regulation of Interleukin-8 in Human Brain Microvascular Endothelial Cells  Shalom Avarham  2002 
 11157197 Capase Inhibitors Attenuate Oxyhemoglobin-Induced Apoptosis in Endothelial Cells  Toshinari Meguro   2001
 11292666 Antiangiogenesis signals by endostatin Masayoshi Shichiri   2001
 11418646 TNF-alpha-Induced Sphingosine 1-Phosphate Inhibits Apoptosis Through a Phosphatidylinositol 3-Kinase/Akt Pathway in Human Hepatocytes  Yosuke Osawa  2001 
11090064 Secreted Phospholipase A2 induces vascular endothelial cell migration  Maria Teresa Rizzo   2000
8423076 Group B Streptococci Invade Endothelial Cells: Type III Capsular Polysaccharide Attenuates Invasion  Ronald L Gibson   1993 
10684811 Human Endometrial Cells: Isolation, Characterization and Inflammatory-Mediated Expression of Tissue Factor and Type 1 Plaminogen Activator Inhibitor Frederick Schatz   2000
9122172 Aputative angiogenin receptor in angiogenin-responsive human endothelial cells  Guo-fu Hu   1997

 

 

Please read our Terms and Conditions.

   

Copyright © 1997-2010 Cell Systems Corporation. All Rights reserved